Back to Search

PAUL SKOLNIK, M.D.

M.D.

Infectious Disease Physician

NPI: 1679521710IndividualAccepts Medicare

Specialties, Licenses & Credentials

Infectious Disease PhysicianPrimary

Internal Medicine — Infectious Disease

Code: 207RI0200X

0101260085(VA)

CMS Specialties

PrimaryINFECTIOUS DISEASE

Education

PERELMAN SCHOOL OF MED AT THE UNIVERSITY OF PENNSYLVANIA

Class of 1981

Research & Publications (20)

Stimulation of peroxisome proliferator-activated receptors alpha and gamma blocks HIV-1 replication and TNFalpha production in acutely infected primary blood cells, chronically infected U1 cells, and alveolar macrophages from HIV-infected subjects.
PMID 12352144·J Acquir Immune Defic Syndr·2002
8-other
Assessing human immunodeficiency virus type 1 tropism: Comparison of assays using replication-competent virus versus plasma-derived pseudotyped virions.
PMID 19494074·J Clin Microbiol·2009
4-observational
Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211.
PMID 19191652·Clin Infect Dis·2009
3-trial
Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384.
PMID 19123865·Clin Infect Dis·2009
2-rct
Predictors of treatment for hepatitis C virus (HCV) infection in drug users.
PMID 19042314·Subst Abus·2008
8-other
Optimal recall period and response task for self-reported HIV medication adherence.
PMID 17577653·AIDS Behav·2008
2-rct
Human immunodeficiency virus infection alters tumor necrosis factor alpha production via Toll-like receptor-dependent pathways in alveolar macrophages and U1 cells.
PMID 18524817·J Virol·2008
8-other
The relationship of post-traumatic stress disorder and depression to antiretroviral medication adherence in persons with HIV.
PMID 18338960·AIDS Patient Care STDS·2008
4-observational
Effect of a four-week course of interleukin-10 on cytokine production in a placebo-controlled study of HIV-1-infected subjects.
PMID 17594937·Eur Cytokine Netw·2007
3-trial
Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211.
PMID 17570119·J Infect Dis·2007
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

Contact & Hours

Address
2001 CRYSTAL SPRING AVE SW STE 301
ROANOKE, VA 24014

Quick Facts

NPI
1679521710
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
45
Publications
20

Are you this provider?

Claim Your Profile